COVID-19 / Coronavirus
Ortho Clinical Diagnostics Recognized With Prestigious Edison Award for Highly Accurate COVID-19 Solutions Capable of Mass-Scale Testing
2021-04-27 05:16
1968
Silver Award Recognizes Antibody and Antigen Tests RARITAN, N.J., April 27, 2021 /PRNewswire/ -- Ortho Clinical Diagnostics (NASDAQ: OCDX), one of the world's largest pure-play in vitro diagnostics (IVD) companies, has been recognized with a prestigious silver 2021 Edison Award for its VITROS® C...
World Malaria Day: Fosun joins in the global fight for a malaria-free world
2021-04-26 19:03
3125
HONG KONG and SHANGHAI, April 26, 2021 /PRNewswire/ -- At 9pm local time on April 25th, the large screen on the building of 28 Liberty in New York City was lit up with the prominent message "ZERO MALARIA STARTS WITH ME". In the next hour, many visitors passing through stopped to watch the mess...
I-Mab Announces Positive Topline Phase 2 Results for Olamkicept in Ulcerative Colitis
2021-04-26 19:00
1628
SHANGHAI and GAITHERSBURG, Md., April 26, 2021 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced positive topline results from its regional multi-center...
One-Stop CLIA Solution with Open Systems and Resources Makes Evolution to Emerging World Healthcare Systems
2021-04-26 15:17
1565
* Advanced, flexible cooperation models delivered by one-stop CLIA solution can boost government industrialization plans, laboratory technology updates, reagent R&D and localization, and even more investment flows to the industry * COVID-19 NAb Test CLIA Solution coupled with COVID-19 Ag Self ...
INOVIO Planning for ex-US Global Phase 3 Trial for INO-4800
2021-04-23 20:00
4310
Given universal eligibility and broad availability of COVID-19 vaccines in the U.S., DoD JPEO-CBRND has notified INOVIO that it will discontinue funding for the Phase 3 INO-4800 trial INOVIO adjusts INO-4800 clinical development strategy to focus on global unmet COVID-19 vaccine needs PLYMOUTH ...
Vaccines: More cooperation, less speculation
2021-04-22 21:00
1559
BEIJING, April 22, 2021 /PRNewswire/ -- A news report by China.org.cn on China's attitude towards China-US trade friction: Recently, there have been media reports saying that a Chinese official "admitted" low effectiveness of the country's COVID-19 vaccines. Given that many countries have alread...
IBM Study: COVID-19 Pandemic Impacted 9 in 10 Surveyed Consumers' Views on Sustainability
2021-04-22 20:00
3034
ARMONK, N.Y., April 22, 2021 /PRNewswire/ -- The COVID-19 pandemic has elevated consumers' focus on sustainability and willingness to pay out of their own pockets – or even take a pay cut – for a sustainable future, according to a new IBM Institute for Business Value (IBV)survey of over 14,000 co...
RDIF and Minapharm agree to produce over 40 million doses of the Sputnik V vaccine in Egypt
2021-04-22 16:00
2363
MOSCOW, CAIRO and BERLIN, April 22, 2021 /PRNewswire/ -- The Russian Direct Investment Fund (RDIF,Russia's sovereign wealth fund), Egypt's Minapharm, the regional leader in recombinant DNA technology, and itsBerlin-based subsidiary, ProBioGen AG, announce the agreement to produce over 40 million ...
Galderma launches new Multichannel Medical Education platform: Inaugural webinar series on the impact of mask wearing on skin diseases
2021-04-22 15:00
1470
- Launching in May, an inaugural four-part webinar series Unmasking Facial Skin & Dermatoses will feature expert presentations from world-renowned dermatologists - The program launches the Galderma Excellence in Multichannel Medical Education (GEMME) platform, demonstrating its commitment to i...
Memorandum of Understanding signed between MURC and AINQA Health Pte. Ltd.
2021-04-22 10:30
1537
LONDON and NEW YORK, April 22, 2021 /PRNewswire/ -- AINQA Health Pte. Ltd. (Headquartered inSingapore, CEO: Kanagasingam Kathirkama Thamby, also "AINQA") and Mitsubishi UFJ Research and Consulting Co., Ltd. (Headquartered inTokyo, President:Satoshi Murabayashi, also "MURC") have signed a Memorand...
Seegene to supply COVID-19 diagnostic tests worth 16 mil. GBP to Scotland, triple the sales volume seen last year
2021-04-22 09:37
2877
* Second public procurement agreement after Italy's procurement deal worth EUR 89.3 million SEOUL, South Korea, April 22, 2021 /PRNewswire/ -- Seegene Inc. (KQ 096530), a leading biotechnology firm said it began supplying its COVID-19 diagnostic tests worth16,209,150 GBP to Scotland under a pub...
World Lupus Federation Global Survey of People with Lupus Finds Half of Respondents Experienced a Decrease in Access to Healthcare During COVID-19 Pandemic
2021-04-22 07:00
2066
Over one third of survey respondents living with lupus were unable to access the COVID-19 vaccineearlier than the general population WASHINGTON, April 22, 2021 /PRNewswire/ -- In a new global survey, more than 6,100 people with lupus from over 85 countries shared their recent experiences of the ...
Innovative and Eco-friendly Masks to Provide Silver Lining for Declining Consumer Face Mask Market
2021-04-22 04:03
1710
For face mask businesses to thrive in the post-COVID-19 era, manufacturers must develop masks with distinct product features, says Frost & Sullivan SANTA CLARA, Calif., April 22, 2021 /PRNewswire/ -- Frost & Sullivan's recent analysis on the global consumer face mask market finds that the mature ...
Cobots Lead the Future of the Global Industrial Robots Market, Finds Frost & Sullivan
2021-04-21 20:48
2213
Asia-Pacific to remain the epicenter of growth opportunities for robot manufacturers, with market revenues estimated to top$25.08 billion by 2024 SANTA CLARA, Calif., April 21, 2021 /PRNewswire/ -- Frost & Sullivan's recent analysis finds that theglobal industrial robotics market will reach reven...
ATH434 protects brain cells and improves motor function in Parkinsonian disorder
2021-04-21 20:11
2227
MELBOURNE, Australia , April 21, 2021 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company") today announced an oral presentation of expanded animal data to support the commercialisation of its lead compound ATH434 in clinical development for the treatment of...
#RosaceaUnmasked by Galderma unites the rosacea community to shine light on the impact of essential COVID-19 mask-wearing this Rosacea Awareness Month
2021-04-21 17:29
1881
- Rosacea sufferers join forces this Rosacea Awareness Month to bravely share the personal impact essential COVID-19 mask-wearing has on their skin condition - #RosaceaUnmasked encourages rosacea sufferers to speak with a doctor or dermatologist about the burden of regular mask-wearing on their r...
Biovaxys And The World Ovarian Cancer Coalition Join Forces For May 8th, World Ovarian Cancer Day
2021-04-20 20:00
3415
VANCOUVER, BC and TORONTO, April 20, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTC: LMNGF) ("BioVaxys"), the world leader in haptenized antigen vaccines for antiviral and cancers applications, announced today its sponsorship of this year's World Ovarian Cancer Day, a ...
One Year After COVID-19 Global Lockdown, Medical Panel Discusses Pandemic Impact on Patients with Underlying Conditions and the Need to Prioritize Chronic Diseases in the Future
2021-04-20 11:53
2448
WASHINGTON, April 20, 2021 /PRNewswire/ -- On Wednesday, April 21st, 2021, from 8:00AM - 9:30AM EDT, the Business Council for International Understanding (BCIU) and Viatris (NASDAQ: VTRS) will co-host a virtual dialogue following the 2021 Spring Meetings of the World Bank Group and the Internatio...
Prenetics Signs Multi-million Dollar Collaboration with Oxford University for Advanced Molecular Diagnostics
2021-04-20 09:00
1681
* The collaboration is a 3-year joint effort by Prenetics R&D Team, Oxford University and Oxford Suzhou for Advanced Research (OSCAR) for Molecular Diagnostics * A new Prenetics Innovation Technology Centre is established for advanced molecular diagnostics * Collaboration follows successful...
CNPharm has succeeded in maintaining IC100 for 24 hours with one injection
2021-04-19 20:15
1379
- Trail-blazing diversification of the repurposing of Niclosamide - Full-scale clinical preparation of injections for severely ill patients SEOUL, South Korea, April 19, 2021 /PRNewswire/ -- Hyundai Bioscience (Symbol 048410), a KOSDAQ listed company, announced on the 19th that its major sharehol...
Week's Top Stories
Most Reposted
Earth Day 2024: Angel Yeast Continues to Tackle Plastic Pollution Challenges With Bio-based Material Solutions
[Picked up by 294 media titles]
2024-04-22 16:00Trina Solar and PetroGreen Partner to Accelerate Philippine Solar Adoption with 117MW Supply Agreement
[Picked up by 291 media titles]
2024-04-22 06:00With unique features, Hainan TV opened "The World's Specialty" pavilion at the Expo!
[Picked up by 287 media titles]
2024-04-18 21:26China's Yiwu Establishes Welcoming Committee to Attract International Buyers
[Picked up by 286 media titles]
2024-04-19 13:25Animated Life in Yunnan
[Picked up by 281 media titles]
2024-04-18 14:00Most Read
With unique features, Hainan TV opened "The World's Specialty" pavilion at the Expo!
2024-04-18 21:26
8839
Animated Life in Yunnan
2024-04-18 14:00
7829
China's Yiwu Establishes Welcoming Committee to Attract International Buyers
2024-04-19 13:25
7751